Shire Names Canadian John Snisarenko Group VP, Ophthalmology Unit
Wednesday, July 5 2017 | 00 h 00 min | News
Shire US recently announced the appointment of John Snisarenko as Group Vice President, Ophthalmology Business Unit. He replaces Robert Dempsey, who is moving to Shire Global as VP and Head of Global Ophthalmics.
John Snisarenko was previously VP Sales and Marketing, Rheumatology, at Genentech USA. Snisarenko has 30 years experience within the industry, having also worked at Novartis Pharma Canada, CIBA Vision and Novadaq Technologies, among others. He attended McGill University, where he received his MBA and his BSc in Biochemistry.
“I am joining Shire on the eve of the first anniversary of the ophthalmics franchise first marketed product, Xiidra, whose market performance has exceeded expectations,” Mr. Snisarenko said in a company statement. “I look forward to continuing to build on the successes of the Ophthalmics franchise, including advancing our pipeline and footprint in the eye care space.”
Read more at: http://eyewiretoday.com/2017/06/20/shire-announces-appointment-of-john-snisarenko-to-group-vp–head-of-ophthlamics/
